Company Profiles

driven by the PitchBook Platform

Angstrom Pharmaceuticals

Description

Developer of a new class of proprietary drugs that treat diseases involving cell migration, invasion and metastasis. The company offers A6, a urokinase plasminogen activator-derived peptide for cancers and age-related macular degeneration.

1996

Founded

PRIVATE

Status

1-10

Employees

Angel

Latest Deal Type

$20k

Latest Deal Amount

$14.8M

Total Amount Raised

Description

Developer of a new class of proprietary drugs that treat diseases involving cell migration, invasion and metastasis. The company offers A6, a urokinase plasminogen activator-derived peptide for cancers and age-related macular degeneration.

Website:

www.angstrominc.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Primary Office

990 Highland Drive Suite 110V Solana Beach, CA 92075United States +1 (858) 314-2356
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Angstrom Pharmaceuticals's full profile, request a free trial.

Angstrom Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Angstrom Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Angstrom Pharmaceuticals Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Hamilton BioVenturesVenture CapitalMinority000 0000000 0000
Pacific Gate CompanyCorporationMinority000 0000000 0000
Solstice CapitalVenture CapitalMinority000 0000000 0000
Tech Coast AngelsAngel GroupMinority000 0000000 0000
Hamilton BioVentures Venture Capital
Pacific Gate Company Corporation
Solstice Capital Venture Capital
Tech Coast Angels Angel Group

Angstrom Pharmaceuticals Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Malcolm Finlayson Ph.DChief Executive Officer & President
Dale KostmanChief Financial Officer
Terence Jones Ph.DFounder & Chief Technology Officer
Virgil Thompson Ph.DAdvisor
Malcolm Finlayson Ph.D Chief Executive Officer & President
Dale Kostman Chief Financial Officer
Terence Jones Ph.D Founder & Chief Technology Officer
Virgil Thompson Ph.D Advisor

Angstrom Pharmaceuticals Board Members (6)

NameRepresentingRoleSinceContact
Info
Chi YapSelfBoard Member000 0000
David U'Prichard Ph.DSelfBoard Member000 0000
Donald GrimmHamilton BioVenturesBoard Member000 0000
Kerry Dance Ph.DAngstrom PharmaceuticalsChairman000 0000
Martin NashSelfBoard Member000 0000
Chi Yap Board Member Self
David U'Prichard Ph.D Board Member Self
Donald Grimm Board Member Hamilton BioVentures
Kerry Dance Ph.D Chairman Angstrom Pharmaceuticals
Martin Nash Board Member Self
Request full access to PitchBook